FlowOx 2.0

DEVICE2 trials

Sponsors

Otivio AS

Conditions

Multiple SclerosisPainPain, ChronicSpasticity, Muscle

Unknown Phase

Performance and Long-term Safety of FlowOx2.0™ in Patients With Multiple Sclerosis - Impact on Spasticity and Pain

Otivio ASMultiple Sclerosis, Pain, Chronic, Spasticity, Muscle

Start: 2022-10-04End: 2023-08-15Updated: 2023-06-29

Performance and Long-term Safety of FlowOx2.0™, Multiple Sclerosis, Spasticity and Pain

Otivio ASMultiple Sclerosis, Pain, Spasticity, Muscle

Start: 2022-11-04End: 2023-12-31Target: 60Updated: 2023-02-23

Related Papers

Efficacy and Safety of Intermittent Negative Pressure Treatment on Spasticity and Spasticity-Related Symptoms in Patients with Multiple Sclerosis: A Two-Arm Randomized Trial.

2026-07-15